Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-22
2005-03-22
Trinh, Ba K. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S510000, C549S511000
Reexamination Certificate
active
06869973
ABSTRACT:
The present invention describes novel nitrosated and/or nitrosylated taxanes, and novel compositions comprising at least one nitrosated and/or nitrosylated taxane, and, optionally, at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The present invention also provides novel compositions comprising at least one taxane and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The compounds and compositions of the present invention can also be bound to a matrix. The present invention also provides methods for treating or preventing cardiovascular diseases and disorders, autoimmune diseases, pathological conditions resulting from abnormal cell proliferation, polycystic kidney disease, inflammatory disease, preserving organs and/or tissues or to inhibit wound contraction, particularly the prophylactic and/or therapeutic treatment of restenosis, by administering nitrosated and/or nitrosylated taxane or parent taxanes in combination with nitric oxide donors that are capable of releasing nitric oxide or indirectly delivering or transferring nitric oxide to targeted sites under physiological conditions.
REFERENCES:
patent: 4703039 (1987-10-01), Hawiger et al.
patent: 4885173 (1989-12-01), Stanley et al.
patent: 4900719 (1990-02-01), Means et al.
patent: 4960790 (1990-10-01), Stella et al.
patent: 5157049 (1992-10-01), Haugwitz et al.
patent: 5278192 (1994-01-01), Fung et al.
patent: 5282785 (1994-02-01), Shapland et al.
patent: 5284864 (1994-02-01), Holton et al.
patent: 5286254 (1994-02-01), Shapland et al.
patent: 5399726 (1995-03-01), Holton et al.
patent: 5428070 (1995-06-01), Cooke et al.
patent: 5466834 (1995-11-01), Holton
patent: 5482925 (1996-01-01), Hutsell
patent: 5550261 (1996-08-01), Bouchard et al.
patent: 5616608 (1997-04-01), Kinsella et al.
patent: 5629433 (1997-05-01), Zheng et al.
patent: 5646176 (1997-07-01), Golik et al.
patent: 5665077 (1997-09-01), Rosen et al.
patent: 5679400 (1997-10-01), Tuch
patent: 5688977 (1997-11-01), Sisti et al.
patent: 5703117 (1997-12-01), Mayhew et al.
patent: 5760072 (1998-06-01), de Bont et al.
patent: 5773431 (1998-06-01), Javitt
patent: 5797887 (1998-08-01), Rosen et al.
patent: 5800385 (1998-09-01), Demopulos et al.
patent: 5808113 (1998-09-01), Murray et al.
patent: 5811447 (1998-09-01), Kunz et al.
patent: 5824049 (1998-10-01), Ragheb et al.
patent: 5837008 (1998-11-01), Berg et al.
patent: 5852058 (1998-12-01), Cooke et al.
patent: 5861168 (1999-01-01), Cooke et al.
patent: 5886026 (1999-03-01), Hunter et al.
patent: 5912263 (1999-06-01), Meninchincheri et al.
patent: 5916913 (1999-06-01), Joseph
patent: 5919815 (1999-07-01), Bradley et al.
patent: 5945452 (1999-08-01), Cooke et al.
patent: 5951458 (1999-09-01), Hastings et al.
patent: 5965739 (1999-10-01), Kelly et al.
patent: 5977163 (1999-11-01), Li et al.
patent: 5981564 (1999-11-01), Page et al.
patent: 5981568 (1999-11-01), Kunz et al.
patent: 5994444 (1999-11-01), Trescony et al.
patent: 5998656 (1999-12-01), Holton et al.
patent: 6017935 (2000-01-01), Mastalerz et al.
patent: 6017948 (2000-01-01), Rubinfeld et al.
patent: 6028205 (2000-02-01), Holton et al.
patent: 6063407 (2000-05-01), Zapol et al.
patent: 6071952 (2000-06-01), Owens et al.
patent: 6072060 (2000-06-01), Swindell et al.
patent: 6080877 (2000-06-01), Swindell et al.
patent: 6147234 (2000-11-01), Holton et al.
patent: 6177456 (2001-01-01), Yankov et al.
patent: 6231600 (2001-05-01), Zhong
patent: 6262281 (2001-07-01), Swindell et al.
patent: 0 624 377 (1994-11-01), None
patent: 0 639 577 (1995-02-01), None
patent: 0 558 959 (1997-04-01), None
patent: WO 9317121 (1993-09-01), None
patent: WO 9415599 (1994-07-01), None
patent: WO 9503795 (1995-02-01), None
patent: WO 9520582 (1995-08-01), None
patent: WO 9600724 (1996-01-01), None
patent: WO 9616645 (1996-06-01), None
patent: WO 9640091 (1996-12-01), None
patent: WO 9709979 (1997-03-01), None
patent: WO 9710234 (1997-03-01), None
patent: WO 9719938 (1997-06-01), None
patent: WO 9732578 (1997-09-01), None
patent: WO 9733552 (1997-09-01), None
patent: WO 9800419 (1998-01-01), None
patent: WO 9821193 (1998-05-01), None
patent: WO 9824427 (1998-06-01), None
patent: WO 9828288 (1998-07-01), None
patent: WO 9837765 (1998-09-01), None
patent: WO 9838862 (1998-09-01), None
patent: WO 9848852 (1998-11-01), None
patent: WO 9902648 (1999-01-01), None
patent: WO 9914209 (1999-03-01), None
patent: WO 9918949 (1999-04-01), None
patent: WO 9921908 (1999-05-01), None
patent: WO 9931079 (1999-06-01), None
patent: WO 9949901 (1999-10-01), None
patent: WO 9955317 (1999-11-01), None
patent: WO 9957105 (1999-11-01), None
patent: WO 9962510 (1999-12-01), None
patent: WO 0010988 (2000-03-01), None
patent: WO 0061537 (2000-10-01), None
patent: WO 0061541 (2000-10-01), None
patent: WO 0061549 (2000-10-01), None
patent: WO 0110344 (2001-02-01), None
patent: WO 0112584 (2001-02-01), None
Supplementary European Search Report for EP 01 94 8610 dated Feb. 3, 2004.
Bhat et al, Bioorganic & Medicinal Chemistry Letters, 8:3181-3186 (1998).
Díz, J. Fernando, et al., “Changes in Microtubule Protofilament Number Induced by Taxol Binding to an Easily Accessible Site,”The Journal of Biological Chemistry, vol. 273, No. 50, pp. 33803-33810 (Dec. 1998).
Gelmon, Karen, The Taxoids: Paclitaxel and Docetaxel [Drug Profile],The Lancet, vol. 344 (8932), pp. 1267-1272 (Nov. 1994).
Ojima, Iwao, et al., “A Common Pharmacophore for Cytotoxic Natural Products that Stabilize Microtubules,”Proc. Natl. Acad. Sci. USA, vol. 96, pp. 4256-4261 (Apr. 1999).
Rao, Koppaka V., et al., “Selective Nitration of Paclitaxel and Related Taxanes,”Tetrahedron Letters, pp. 4611-4614 (1998).
Rao, Srinivasa, et al., “Characterization of the Taxol Binding Site on the Microtubule,”J. Biol. Chem., vol. 274, Issue 53, pp. 37990-37994 (Dec. 1999).
Takahashi, Takashi, et al., “Design and Synthesis of a Water-Soluble Taxol Analogue: Taxol-Sialyl Conjugate,”Bioorganic&Medicinal Chemistry Letters, pp. 113-116 (1998).
White, James G., et al., “Influence of a Microtubule Stabilizing Agent on Platelet Structural Physiology,”American Journal Pathologists, vol. 112, No. 2, pp. 207-217 (Aug. 1983).
Garvey David S.
Letts L. Gordon
Lin Chia-En
Richardson Stewart K.
Wang Tiansheng
NitroMed Inc.
Trinh Ba K.
Wilmer Cutler Pickering Hale and Dorr LLP
LandOfFree
Nitrosated and nitrosylated taxanes, compositions and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitrosated and nitrosylated taxanes, compositions and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitrosated and nitrosylated taxanes, compositions and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3382626